CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Albireo Pharma, Inc.  (ALBO)
Other Ticker:  
 
    Sector  Healthcare    Industry Major Pharmaceutical Preparations
 

Albireo Pharma's Gross Margin by quarter

Trends, Rankings, Statistics

Select the Comparisons : Select the Ratio:                        

ALBO Gross Margin (Mar 31 2017)
I. Quarter
(Dec 31 2016)
IV. Quarter



Y / Y Revenue Change - - - - -
Y / Y Gross Profit Change - - - - -
Gross Margin - - - - -
Gross Margin Total Ranking # 565 # # # #
Seq. Revenue Change - - - - -
Seq. Gross Profit Change - - - - -


Commenting First Quarter 2017 Gross Margin
Albireo Pharma, Inc. achieved Gross Profit of $0 millions compare to Gross Loss of $0.00 millions recorded in previous quarter. Revenue increased by 0 % Company achieved below average Gross Margin with 100 %.

Observing first quarter 2017 results within Major Pharmaceutical Preparations industry 71 other companies have achieved higher Gross Margin. While Gross Margin overall ranking has deteriorated compare to previous quarter from to 565.
Learn about Gross Margin
ALBO's Gross Margin first quarter 2017 Company Ranking
Within: No.
Industry # 72
Sector # 148
S&P 500 # 565

Gross Margin Statistics
High Average Low
100 % 100 % 100 %
(Mar 31 2017)  

You need to upgrade your Flash Player


Financial Statements
Albireo Pharma's (Mar 31 2017) Gross Profit $ 0 ALBO's Income Statement
Albireo Pharma's Gross Profit $ 0 Quarterly ALBO's Growth
ALBO's Profits by Division See ALBO's Profits by Segment

Other Gross Margin Profitability Ratios
ALBO's Cumulative Gross Margin
Major Pharmaceutical Preparations Industry Gross Margin Trends and Statistics
Healthcare Sector Gross Margin Statistics
Gross Margin Profitability Trends for overall market
ALBO's Gross Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Gross Margin
Lowest Ranking Gross Margin
Gross Margin Profit Margin for ALBO's Competitors
Gross Margin Profit Margin for Albireo Pharma's Suppliers
Gross Margin Profit Margin for ALBO's Customers

You may also want to know
ALBO's Annual Growth Rates ALBO's Profitability Ratios ALBO's Asset Turnover Ratio ALBO's Dividend Growth
ALBO's Roe ALBO's Valuation Ratios ALBO's Financial Strength Ratios ALBO's Gross Profit Growth
ALBO's Roa ALBO's Inventory Turnover Ratio ALBO's Growth Rates ALBO's Dividend Comparisons


Companies with similar Gross Margin in the quarter ending Mar 31 2017, within Major Pharmaceutical Preparations Industry Gross MarginMar 31 2017 MRQ Gross ProfitMar 31 2017 MRQ Revenue
Onconova Therapeutics, Inc.  100.00 %$ 0.210 $ 0.210 
Ophthotech Corp.  100.00 %$ 1.662 $ 1.662 
Progenics Pharmaceuticals Inc  100.00 %$ 2.347 $ 2.347 
Corbus Pharmaceuticals Holdings, Inc.  100.00 %$ 1.294 $ 1.294 
Oncomed Pharmaceuticals Inc  100.00 %$ 6.213 $ 6.213 
Dermira, Inc.  100.00 %$ 1.066 $ 1.066 
Novan, Inc.  100.00 %$ 0.100 $ 0.100 
Northwest Biotherapeutics Inc  100.00 %$ 0.068 $ 0.068 
Pharmathene, Inc  100.00 %$ 0.804 $ 0.804 
Prothena Corp Plc  100.00 %$ 0.259 $ 0.259 
Checkpoint Therapeutics, Inc.  100.00 %$ 0.693 $ 0.693 
Cerulean Pharma Inc.  100.00 %$ 1.192 $ 1.192 
Cempra, Inc.  100.00 %$ 4.872 $ 4.872 
Clearside Biomedical, Inc.  100.00 %$ 0.005 $ 0.005 
Celsion Corp  100.00 %$ 0.125 $ 0.125 
Conatus Pharmaceuticals Inc.  100.00 %$ 6.998 $ 6.998 
Chimerix Inc  100.00 %$ 1.078 $ 1.078 
Paratek Pharmaceuticals, Inc.  100.00 %$ 0.018 $ 0.018 
Dicerna Pharmaceuticals Inc  100.00 %$ 0.133 $ 0.133 
Newlink Genetics Corp  100.00 %$ 2.761 $ 2.761 
Ionis Pharmaceuticals Inc  100.00 %$ 110.304 $ 110.304 
Fibrogen Inc  100.00 %$ 26.891 $ 26.891 
Intra-cellular Therapies, Inc.  100.00 %$ 0.095 $ 0.095 
Abeona Therapeutics Inc.  100.00 %$ 0.186 $ 0.186 
Five Prime Therapeutics Inc  100.00 %$ 10.135 $ 10.135 
Heat Biologics, Inc.  100.00 %$ 0.024 $ 0.024 
Geron Corp  100.00 %$ 0.537 $ 0.537 
Immunogen Inc  100.00 %$ 28.499 $ 28.499 
Eyegate Pharmaceuticals Inc  100.00 %$ 0.185 $ 0.185 
Enanta Pharmaceuticals Inc  100.00 %$ 8.959 $ 8.959 


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com